107 related articles for article (PubMed ID: 15437)
21. [Sero-epidemiologic study of Epstein-Barr virus markers in patients without mononucleosis at a department for infectious diseases].
Ternák G; Uj M; Szücs G; Bali I; Almási I; Kócsi J
Orv Hetil; 1995 Dec; 136(50):2727-30. PubMed ID: 8532326
[TBL] [Abstract][Full Text] [Related]
22. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
23. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
[TBL] [Abstract][Full Text] [Related]
24. Studies on the presence of antibodies to EB virus and other herpesviruses in normal children and in infectious mononucleosis.
Gergely L; Czeglédy J; Váczi L; Szabó B; Binder L; Szalka A
Acta Microbiol Acad Sci Hung; 1975; 22(2):75-82. PubMed ID: 164758
[TBL] [Abstract][Full Text] [Related]
25. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of a dot-blot technique for the detection of Epstein-Barr virus antibodies (IgG anti-viral capsid antigen)].
Bouillet L; Cattoen C; Keilani A; Chatelain C; Mazars E
Ann Biol Clin (Paris); 1998; 56(1):79-83. PubMed ID: 9754226
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
[TBL] [Abstract][Full Text] [Related]
29. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
30. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
31. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
Harada M; Sairenji T; Takaki K; Hinuma Y
Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear antigen (EBNA)-positive cells in a lymph-node of a child with severe primary EBV infection.
Lenoir G; De-The G; Virelizier JL; Griscelli C
IARC Sci Publ (1971); 1978; (24 Pt 2):733-8. PubMed ID: 221396
[No Abstract] [Full Text] [Related]
33. Infectious mononucleosis and its relationship to EB virus antibody. A joint investigation by university health physicians and P.H.L.S. laboratories.
Br Med J; 1971 Dec; 4(5788):643-6. PubMed ID: 4332464
[TBL] [Abstract][Full Text] [Related]
34. IgA antibodies to Epstein-Barr virus in infectious mononucleosis.
Marklund G; Henle W; Henle G; Ernberg I
Scand J Infect Dis; 1986; 18(2):111-9. PubMed ID: 3010447
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of serological and molecular biological tests for infectious mononucleosis by EBV in different age stages and course of the disease.
Shi T; Huang L; Luo L; Yu Q; Tian J
J Med Virol; 2021 Jun; 93(6):3824-3834. PubMed ID: 32978964
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to Epstein-Barr virus in infectious mononucleosis.
Nikoskelainen J; Hänninen P
Infect Immun; 1975 Jan; 11(1):42-51. PubMed ID: 163790
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of six commercially available kits using purified heterophile antigen for the rapid diagnosis of infectious mononucleosis compared with Epstein-Barr virus-specific serology.
Elgh F; Linderholm M
Clin Diagn Virol; 1996 Oct; 7(1):17-21. PubMed ID: 9077426
[TBL] [Abstract][Full Text] [Related]
38. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
Sairenji T; Sullivan JL; Humphreys RE
J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
[TBL] [Abstract][Full Text] [Related]
39. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
Schmitz H; Kampa D; Heidenreich W
Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex.
Horwitz CA; Henle W; Henle G; Schmitz H
Am J Med; 1975 Mar; 58(3):330-8. PubMed ID: 163582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
